290 related articles for article (PubMed ID: 2894223)
1. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
Ades PA
Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
[TBL] [Abstract][Full Text] [Related]
2. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
Svendsen TL
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
[TBL] [Abstract][Full Text] [Related]
3. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
Ades PA; Wolfel EE; Hiatt WR; Fee C; Rolfs R; Brammell HL; Horwitz LD
Eur J Clin Pharmacol; 1989; 36(1):5-10. PubMed ID: 2917588
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of pindolol.
Aellig WH
Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.
Hombach V; Braun V; Höpp HW; Gil-Sanchez D; Behrenbeck DW; Tauchert M; Hilger HH
Br J Clin Pharmacol; 1982; 13(Suppl 2):285S-293S. PubMed ID: 6125178
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic sympathomimetic activity: clinical fact or fiction?
Taylor SH
Am J Cardiol; 1983 Nov; 52(9):16D-26D. PubMed ID: 6139009
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta blockade and intrinsic sympathomimetic activity on exercise performance.
Ades PA; Brammell HL; Greenberg JH; Horwitz LD
Am J Cardiol; 1984 Dec; 54(10):1337-41. PubMed ID: 6507309
[TBL] [Abstract][Full Text] [Related]
9. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
Yonga GO; Oyuga HW; Njeru EK
East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoceptor blockade and atrio-ventricular conduction in dogs. Role of intrinsic sympathomimetic activity.
Giudicelli JF; Lhoste F
Br J Clin Pharmacol; 1982; 13(Suppl 2):167S-174S. PubMed ID: 6125166
[TBL] [Abstract][Full Text] [Related]
11. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
Jakubetz J; Schmuck S; Poller U; Fuchs B; Gorf A; Radke J; Pönicke K; Brodde OE
J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol.
Aellig WH
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S16-20. PubMed ID: 6188915
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of pindolol and propranolol on exercise performance in young men with systemic hypertension.
Martin NB; Broeder CE; Thomas EL; Wambsgans KC; Scruggs KD; Jesek JK; Hofman Z; Wilmore JH
Am J Cardiol; 1989 Aug; 64(5):343-7. PubMed ID: 2756879
[TBL] [Abstract][Full Text] [Related]
14. Effects of propranolol and pindolol on cardiac output during extended periods of low-intensity physical activity.
Broeder CE; Thomas EL; Martin NB; Hofman Z; Jesek JK; Scruggs KD; Wambsgans KC; Wilmore JH
Am J Cardiol; 1993 Nov; 72(15):1188-95. PubMed ID: 8237812
[TBL] [Abstract][Full Text] [Related]
15. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines.
Bilski A; Robertson HH; Wale JL
Clin Exp Pharmacol Physiol; 1979; 6(1):1-9. PubMed ID: 32980
[TBL] [Abstract][Full Text] [Related]
16. The additional properties of beta adrenoceptor blocking drugs.
Prichard BN; Tomlinson B
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-15. PubMed ID: 2427833
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of beta-blockers with and without intrinsic sympathomimetic activity on hemodynamics and left ventricular function at rest and during exercise in patients with coronary artery disease.
Choong CY; Roubin GS; Harris PJ; Tokuyasu Y; Shen WF; Bautovich GJ; Kelly DT
J Cardiovasc Pharmacol; 1986; 8(3):441-8. PubMed ID: 2425156
[TBL] [Abstract][Full Text] [Related]
18. The effect of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on circadian heart rate.
Fitscha P; Tiso B; Meisner W; Spitzer D
Br J Clin Pharmacol; 1982; 13(Suppl 2):211S-215S. PubMed ID: 6125172
[TBL] [Abstract][Full Text] [Related]
19. Can ISA compensate for bradycardia due to beta-adrenoceptor blockade?
Lohmöller G; Stocker K
Br J Clin Pharmacol; 1982; 13(Suppl 2):315S. PubMed ID: 6125182
[No Abstract] [Full Text] [Related]
20. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
